Position in GILD
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,441,413
-$97,510 QoQ
Shares Held
11,409
+3.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
#939
of 2,266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IAM Advisory, LLC holds $17,989,599 across 8 Drug Manufacturers - General names. GILD ranks #6 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,638 | $5,562,956 | |
| 2 | MRK |
Merck & Co., Inc.
|
23,515 | $3,021,677 | |
| 3 | AMGN |
Amgen Inc
|
7,484 | $2,710,106 | |
| 4 | NVS |
Novartis AG
|
16,635 | $2,607,037 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
33,075 | $1,905,781 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
11,409 | $1,441,413 | |
| 7 | JNJ |
Johnson & Johnson
|
1,535 | $389,843 | |
| 8 | ABBV |
AbbVie Inc.
|
1,394 | $350,786 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,441,413 | 11,409 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,538,923 | 11,042 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $1,273,427 | 10,375 | Shares | Sole | 2026-01-07 | |
| No filing history on record for this holder in this stock. | ||||||